HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molly Musarara Selected Research

Chromogenic Compounds

10/2022Dosing for Personalized Prophylaxis in Hemophilia A Highly Varies on the Underlying Population Pharmacokinetic Models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Molly Musarara Research Topics

Disease

1Hemophilia A (Haemophilia)
10/2022

Drug/Important Bio-Agent (IBA)

1Chromogenic CompoundsIBA
10/2022
1Factor VIII (Coagulation Factor VIII)IBA
10/2022

Therapy/Procedure

1Therapeutics
10/2022